Overview

Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Our head office and laboratories are located in Mississauga, Ontario, Canada. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) we develop products that we sell under Covalon’s name; and, (ii) we develop and commercialize medical products for other medical companies under development and license contracts.  The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTQX Market under the symbol CVALF.  Covalon is incorporated under the laws of Ontario.

Stock Info
TSXVCOV
Press Releases
Jan 14, 2022

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that it has appointed Jason F. Gorel as its interim...

Dec 24, 2021

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that Danny Brannagan, its Chief Financial Officer, will...

Dec 13, 2021

Year-end net profit of $23.5 million or $0.91 per share which includes net income from the sale of the AquaGuard operations Revenue from continuing operations increased 45% to $19.6 million for...

View All

Email Alerts
* Required Fields
Events
Monday, December 13, 2021
9:00am - 10:00am EST
Wednesday, December 8, 2021
Monday, August 30, 2021
9:00am - 10:00am EDT

View All

Contact Us

For investor relations inquiries, please contact Brian Pedlar (CEO).
e-mail: bpedlar@covalon.com

To contact the Board of Directors to provide comments, report concerns, or ask a question, please contact Amir Boloor (Chair of the Board).
e-mail: aboloor@covalon.com

 

Contact Form